drugset / Trial / NCT03787043

A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg

NCT03787043

Phase 1 Completed 30 enrolled Handok Inc.
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare the safety and pharmacokinetic characteristics of fixed-dose combination of MP-513 10mg and metformin XR 750mg administered in a high fat fed state versus fasting state to healthy male volunteers.

Timeline

Start
2014-05
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 750 mg
Subject Teneligliptin Small molecule 10 mg

Indications

No indication recorded.